DD267910A5 - Verfahren zur herstellung eines fuer die parenterale verarbeitung eines somatotorpins an ein tier angepassten formkoerper - Google Patents

Verfahren zur herstellung eines fuer die parenterale verarbeitung eines somatotorpins an ein tier angepassten formkoerper Download PDF

Info

Publication number: DD267910A5
Authority: DD; German Democratic Republic
Prior art keywords: somatotropin; day; aps; adg; increase
Prior art date: 1987-03-16

Application number

DD31369488A

Other languages

German (de)

English (en)

Inventor

Michael J Azain

Kenneth E Eigenberg

Thomas R Kasser

Milton J Sabacky

Original Assignee

Monsanto Company,Us

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-03-16

Filing date

1988-03-15

Publication date

1989-05-17

1988-03-15 Application filed by Monsanto Company,Us filed Critical Monsanto Company,Us

1989-05-17 Publication of DD267910A5 publication Critical patent/DD267910A5/de

Links

238000004519 manufacturing process Methods 0.000 title claims abstract description 30
241001465754 Metazoa Species 0.000 title claims abstract description 24
108010051696 Growth Hormone Proteins 0.000 claims abstract description 177
102000018997 Growth Hormone Human genes 0.000 claims abstract description 177
239000011248 coating agent Substances 0.000 claims abstract description 26
238000000576 coating method Methods 0.000 claims abstract description 26
239000000314 lubricant Substances 0.000 claims abstract description 26
239000000203 mixture Substances 0.000 claims abstract description 21
238000009472 formulation Methods 0.000 claims abstract description 5
239000007787 solid Substances 0.000 claims abstract description 4
238000007911 parenteral administration Methods 0.000 claims abstract description 3
239000010949 copper Substances 0.000 claims description 50
238000000034 method Methods 0.000 claims description 40
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 35
229910052802 copper Inorganic materials 0.000 claims description 34
108010006025 bovine growth hormone Proteins 0.000 claims description 9
150000001879 copper Chemical class 0.000 claims description 4
150000002942 palmitic acid derivatives Chemical class 0.000 claims description 2
101000868144 Sus scrofa Somatotropin Proteins 0.000 claims 1
XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical class [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 claims 1
238000000465 moulding Methods 0.000 abstract description 52
239000012778 molding material Substances 0.000 abstract 1
241000283690 Bos taurus Species 0.000 description 72
239000000243 solution Substances 0.000 description 45
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 38
241000282887 Suidae Species 0.000 description 35
235000013336 milk Nutrition 0.000 description 34
239000008267 milk Substances 0.000 description 34
210000004080 milk Anatomy 0.000 description 34
239000007943 implant Substances 0.000 description 28
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 20
238000011282 treatment Methods 0.000 description 20
235000019359 magnesium stearate Nutrition 0.000 description 19
230000000694 effects Effects 0.000 description 14
239000011159 matrix material Substances 0.000 description 14
239000000843 powder Substances 0.000 description 13
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 12
238000002513 implantation Methods 0.000 description 12
239000003826 tablet Substances 0.000 description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
238000003825 pressing Methods 0.000 description 11
150000003839 salts Chemical class 0.000 description 11
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 10
229910000030 sodium bicarbonate Inorganic materials 0.000 description 10
235000017557 sodium bicarbonate Nutrition 0.000 description 10
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
238000007792 addition Methods 0.000 description 9
238000006243 chemical reaction Methods 0.000 description 9
239000013642 negative control Substances 0.000 description 9
239000013641 positive control Substances 0.000 description 9
238000004090 dissolution Methods 0.000 description 8
230000002035 prolonged effect Effects 0.000 description 8
KIUYPHAMDKDICO-WHFBIAKZSA-N Ala-Asp-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O KIUYPHAMDKDICO-WHFBIAKZSA-N 0.000 description 7
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 7
239000004202 carbamide Substances 0.000 description 7
238000000502 dialysis Methods 0.000 description 7
-1 doxtrin Polymers 0.000 description 7
230000008569 process Effects 0.000 description 7
239000000047 product Substances 0.000 description 7
229940045870 sodium palmitate Drugs 0.000 description 7
GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 7
108020004511 Recombinant DNA Proteins 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
150000001413 amino acids Chemical group 0.000 description 6
239000000872 buffer Substances 0.000 description 6
238000011026 diafiltration Methods 0.000 description 6
239000004459 forage Substances 0.000 description 6
230000014509 gene expression Effects 0.000 description 6
238000002347 injection Methods 0.000 description 6
239000007924 injection Substances 0.000 description 6
150000002500 ions Chemical class 0.000 description 6
239000000463 material Substances 0.000 description 6
210000002966 serum Anatomy 0.000 description 6
238000007920 subcutaneous administration Methods 0.000 description 6
230000003442 weekly effect Effects 0.000 description 6
150000001450 anions Chemical class 0.000 description 5
239000011230 binding agent Substances 0.000 description 5
230000000975 bioactive effect Effects 0.000 description 5
150000001768 cations Chemical class 0.000 description 5
150000001875 compounds Chemical class 0.000 description 5
238000004108 freeze drying Methods 0.000 description 5
238000011068 loading method Methods 0.000 description 5
229920001184 polypeptide Polymers 0.000 description 5
239000002244 precipitate Substances 0.000 description 5
102000004196 processed proteins & peptides Human genes 0.000 description 5
108090000765 processed proteins & peptides Proteins 0.000 description 5
230000001105 regulatory effect Effects 0.000 description 5
239000000126 substance Substances 0.000 description 5
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
239000007853 buffer solution Substances 0.000 description 4
210000004027 cell Anatomy 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
230000001276 controlling effect Effects 0.000 description 4
235000013365 dairy product Nutrition 0.000 description 4
230000003628 erosive effect Effects 0.000 description 4
230000001681 protective effect Effects 0.000 description 4
238000003307 slaughter Methods 0.000 description 4
229910052725 zinc Inorganic materials 0.000 description 4
239000011701 zinc Substances 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
241000282898 Sus scrofa Species 0.000 description 3
239000002253 acid Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000000481 breast Anatomy 0.000 description 3
238000005056 compaction Methods 0.000 description 3
239000012634 fragment Substances 0.000 description 3
239000011777 magnesium Substances 0.000 description 3
229910052751 metal Inorganic materials 0.000 description 3
239000002184 metal Substances 0.000 description 3
150000002739 metals Chemical class 0.000 description 3
239000002245 particle Substances 0.000 description 3
238000001556 precipitation Methods 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
108020004414 DNA Proteins 0.000 description 2
101100457042 Dictyostelium discoideum mgst gene Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 2
229910000147 aluminium phosphate Inorganic materials 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
239000002260 anti-inflammatory agent Substances 0.000 description 2
229940121363 anti-inflammatory agent Drugs 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000008366 buffered solution Substances 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
229910000365 copper sulfate Inorganic materials 0.000 description 2
ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
239000008367 deionised water Substances 0.000 description 2
229910021641 deionized water Inorganic materials 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
238000001035 drying Methods 0.000 description 2
235000013305 food Nutrition 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
239000011872 intimate mixture Substances 0.000 description 2
229910052749 magnesium Inorganic materials 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
238000002156 mixing Methods 0.000 description 2
150000002894 organic compounds Chemical class 0.000 description 2
230000009467 reduction Effects 0.000 description 2
238000007493 shaping process Methods 0.000 description 2
235000019786 weight gain Nutrition 0.000 description 2
230000004584 weight gain Effects 0.000 description 2
KRKNYBCHXYNGOX-UHFFFAOYSA-L 2-(carboxymethyl)-2-hydroxysuccinate Chemical compound [O-]C(=O)CC(O)(C(=O)O)CC([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-L 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
LIWMQSWFLXEGMA-WDSKDSINSA-N Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)N LIWMQSWFLXEGMA-WDSKDSINSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
206010019909 Hernia Diseases 0.000 description 1
241000282412 Homo Species 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
206010062767 Hypophysitis Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
241001494479 Pecora Species 0.000 description 1
229920002230 Pectic acid Polymers 0.000 description 1
241000286209 Phasianidae Species 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
229920001800 Shellac Polymers 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
239000003929 acidic solution Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
235000021052 average daily weight gain Nutrition 0.000 description 1
JPNZKPRONVOMLL-UHFFFAOYSA-N azane;octadecanoic acid Chemical class [NH4+].CCCCCCCCCCCCCCCCCC([O-])=O JPNZKPRONVOMLL-UHFFFAOYSA-N 0.000 description 1
229910052788 barium Inorganic materials 0.000 description 1
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
235000013871 bee wax Nutrition 0.000 description 1
239000012166 beeswax Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
229910052797 bismuth Inorganic materials 0.000 description 1
JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
235000019846 buffering salt Nutrition 0.000 description 1
229910052793 cadmium Inorganic materials 0.000 description 1
BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000002775 capsule Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
229920006217 cellulose acetate butyrate Polymers 0.000 description 1
235000013330 chicken meat Nutrition 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
238000011260 co-administration Methods 0.000 description 1
229910017052 cobalt Inorganic materials 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
238000007906 compression Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000011162 core material Substances 0.000 description 1
238000009402 cross-breeding Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000000280 densification Methods 0.000 description 1
235000019621 digestibility Nutrition 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
239000005038 ethylene vinyl acetate Substances 0.000 description 1
235000021050 feed intake Nutrition 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000000227 grinding Methods 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
150000002484 inorganic compounds Chemical class 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
238000002955 isolation Methods 0.000 description 1
230000006651 lactation Effects 0.000 description 1
125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
239000007932 molded tablet Substances 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
210000002445 nipple Anatomy 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000006072 paste Substances 0.000 description 1
239000008188 pellet Substances 0.000 description 1
230000035515 penetration Effects 0.000 description 1
230000001817 pituitary effect Effects 0.000 description 1
210000003635 pituitary gland Anatomy 0.000 description 1
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
239000004632 polycaprolactone Substances 0.000 description 1
229920001610 polycaprolactone Polymers 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000010318 polygalacturonic acid Substances 0.000 description 1
229920000155 polyglutamine Polymers 0.000 description 1
108010040003 polyglutamine Proteins 0.000 description 1
239000004626 polylactic acid Substances 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000004926 polymethyl methacrylate Substances 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
244000144977 poultry Species 0.000 description 1
235000013594 poultry meat Nutrition 0.000 description 1
MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
229960004919 procaine Drugs 0.000 description 1
239000011253 protective coating Substances 0.000 description 1
230000005855 radiation Effects 0.000 description 1
239000004208 shellac Substances 0.000 description 1
235000013874 shellac Nutrition 0.000 description 1
ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
229940113147 shellac Drugs 0.000 description 1
229920000260 silastic Polymers 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
210000001875 somatotroph Anatomy 0.000 description 1
241000894007 species Species 0.000 description 1
238000001694 spray drying Methods 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
235000018553 tannin Nutrition 0.000 description 1
229920001864 tannin Polymers 0.000 description 1
239000001648 tannin Substances 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
210000003905 vulva Anatomy 0.000 description 1
150000003751 zinc Chemical class 0.000 description 1

Landscapes

Medicinal Preparation (AREA)

DD31369488A 1987-03-16 1988-03-15 Verfahren zur herstellung eines fuer die parenterale verarbeitung eines somatotorpins an ein tier angepassten formkoerper DD267910A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US2609587A	1987-03-16	1987-03-16

Publications (1)

Publication Number	Publication Date
DD267910A5 true DD267910A5 (de)	1989-05-17

Family

ID=21829869

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD31369488A DD267910A5 (de)	1987-03-16	1988-03-15	Verfahren zur herstellung eines fuer die parenterale verarbeitung eines somatotorpins an ein tier angepassten formkoerper

Country Status (3)

Country	Link
CS (1)	CS274542B2 (cs)
DD (1)	DD267910A5 (cs)
ZA (1)	ZA881843B (cs)

1988
- 1988-03-15 CS CS168288A patent/CS274542B2/cs unknown
- 1988-03-15 DD DD31369488A patent/DD267910A5/de not_active IP Right Cessation
- 1988-03-15 ZA ZA881843A patent/ZA881843B/xx unknown

Also Published As

Publication number	Publication date
ZA881843B (en)	1988-12-28
CS168288A2 (en)	1990-10-12
CS274542B2 (en)	1991-08-13

Legal Events

Date	Code	Title	Description
1999-07-22	ENJ	Ceased due to non-payment of renewal fee

Publication	Publication Date	Title
DE3883254T2 (de)	1993-12-16	Verfahren zur verlängerten Freisetzung von Somatotropin.
DE69909794T2 (de)	2004-06-09	Verwendung eines dipeptids für wiederherstellungsprozesse
DE69926504T2 (de)	2006-06-08	Zubereitungen zur kontrollierten freisetzung mit mehrschichtstruktur
DE69917883T2 (de)	2005-06-02	Phospholipid-beschichtete Mikrokristalle für die länger anhaltende Freisetzung von pharmakologisch aktiven Verbindungen und Verfahren zu deren Herstellung und deren Verwendung
DE69233115T2 (de)	2004-05-06	Weitere therapeutische Verwendungen von L-Methionine und Zusammensetzungen
DE69523912T2 (de)	2002-06-27	Flubendazole-kautabletten für haustiere
DD244914A5 (de)	1987-04-22	Verfahren zur herstellung einer weitgehend nicht-waessrigen, polypeptidhaltigen zusammensetzung
DE2836631A1 (de)	1979-03-08	Vaginalpraeparat
DE2618129A1 (de)	1976-11-11	Feste, subkutan implantierbare pille, enthaltend eine biologisch wirksame menge an 2 alpha-methylandrostan-17beta- 0l-3-on-17-propionat, verfahren zu deren herstellung und anwendung
DE69322958T2 (de)	1999-05-27	Stabilisiertes somatotropin zur parenteralen verabreichung
DE3687575T2 (de)	1993-07-01	Verwendung von 6-methylen-6-desoxy-n-cyclopropylmethyl-14-hydroxydihydronormorphin.
DE69414863T2 (de)	1999-04-22	Behälter, der ein hydrophober arzneimittel enthält
DE60309447T3 (de)	2020-04-23	Verfahren zur verabreichung von injizierbarem antibiotikum in dem ohr eines tieres
DE69231263T2 (de)	2000-12-21	Calcitonin enthaltende pharmazeutische Zusammensetzungen
DE1808948A1 (de)	1969-07-10	Schmerzlos injizierbares Arzneimittelgemisch
DE602004012731T2 (de)	2009-04-09	Zubereitungen mit verzögerter freigabe enthaltend zink, und herstellung derselben
EP0314421A1 (en)	1989-05-03	Somatotropin formulations
DE69220229T2 (de)	1997-11-06	Somatotropin zur erhoehung der reproduktiven leistung in rinder
DE68906111T2 (de)	1993-09-09	Koerperqualitaet.
DE2618422A1 (de)	1976-11-11	Parenteral verabreichbare cefazolinsuspension
CH634546A5 (de)	1983-02-15	Verfahren zur herstellung von komplexen verbindungen von aminodicarbonsaeuren mit magnesium und halogenen.
AU2006223699B2 (en)	2009-02-12	Agent administration
WO1996025938A1 (en)	1996-08-29	Nutrient metal ion solutions and method of administration
AP105A (en)	1990-11-07	Treatment of animals.
JPH02286046A (ja)	1990-11-26	家畜類の餌及び給餌方法